Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Neurotoxicity Research|July 5, 2011
BACE1 elevation is involved in amyloid plaque development in the triple transgenic model of Alzheimer's disease: differential Aβ antibody labeling of early-onset axon terminal pathologyYan Cai, Xue-Mei Zhang, Lauren N Macklin, et al.
The European Journal of Neuroscience|August 24, 2010
β-Secretase-1 elevation in aged monkey and Alzheimer's disease human cerebral cortex occurs around the vasculature in partnership with multisystem axon terminal pathogenesis and β-amyloid accumulationYan Cai, Kun Xiong, Xue-Mei Zhang, et al.
Health Research Policy and Systems|May 24, 2020
Bridging the gap: an economic case study of the impact and cost effectiveness of comprehensive healthcare intermediaries in rural MexicoAnne Williamson, Lorena Ponce de León, Francisco Rodríguez Garza, et al.
Pathology|June 11, 2023
Laboratory diagnosis of HIV: a contemporary overview in the Australian contextEloise Williams, Michael Moso, Chuan Lim, et al.
Epilepsia|March 8, 2008
Glutamate and astrocytes--key players in human mesial temporal lobe epilepsy?Tore Eid, Anne Williamson, Tih-Shih W Lee, et al.
Headache|September 4, 2024
Headache diagnosis and treatment: A pilot knowledge and needs assessment among physical therapistsMia T Minen, Christopher Whetten, Danielle Messier, et al.
Frontiers in Neuroanatomy|October 29, 2009
Doublecortin-expressing cells persist in the associative cerebral cortex and amygdala in aged nonhuman primatesXue-Mei Zhang, Yan Cai, Yaping Chu, et al.
Molecular and Cellular Neurosciences|July 6, 2010
Layer I as a putative neurogenic niche in young adult guinea pig cerebrumKun Xiong, Yan Cai, Xue-Mei Zhang, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|January 22, 2026
Effects of estradiol, tamoxifen, and raloxifene on human temporal lobe cortex astroglial cell spreadingIvaldo Silva, Frederick Nicholas Naftolin, Vinicius Oliveira Santana, et al.
Diabetes|February 19, 2009
Medium-chain fatty acids improve cognitive function in intensively treated type 1 diabetic patients and support in vitro synaptic transmission during acute hypoglycemiaKathleen A Page, Anne Williamson, Namyi Yu, et al.
Pageof 8